ADC and SBRT for Recurrent/Metastatic Salivary Gland Carcinoma

Clinical trial NCT07579598 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07579598
Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adenoid Cystic Carcinoma of the Head and Neck SBRT Antibody-drug Conjugates

Start date: 2026-05-01
Primary completion: 2026-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.